JPMorgan Chase & Co. lifted their target price on shares of Perrigo Company PLC (NASDAQ:PRGO) from $180.00 to $190.00 in a research note issued on Monday, AnalystRatingsNetwork.com reports. JPMorgan Chase & Co.’s price objective indicates a potential upside of 13.37% from the company’s current price. Perrigo Company (NYSE:PRGO) stock opened at $167.83 in last session, and closed at $166.95, while the day range of stock is $166.01 – $167.97. The stock showed a positive weekly performance of 2.45%.
LifeVantage Corporation (NASDAQ:LFVN)announced that Douglas C. Robinson, the Company’s President and Chief Executive Officer will be presenting at the 26 Annual ROTH Conference, to be held March 9-12, 2014, at the Ritz-Carlton Laguna Niguel. LifeVantage Corp (NASDAQ:LFVN) stock opened at $1.45, in last session and closed at $1.37, by losing -4.20%. The 52 week range of the stock is $1.10 – $2.68. Company’s market capitalization is $142.40 million.
USANA Health Sciences (NASDAQ:USNA) Director Myron W. Wentz sold 63,805 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, March 4th. USANA Health Sciences, Inc. (NYSE:USNA) stock advanced 0.53% and finished the last session at $75.79. The EPS of the stock remained 5.57. Company’s market capitalization is $1.05 billion.
ProPhase Labs, Inc. (NASDAQ:PRPH) is a manufacturer, marketer and distributor of a ranges of homeopathic and health products that are offered to the general public. The Company is also engaged in the research and development of potential over-the-counter (OTC) drugs, natural base health products along with supplements, personal care and cosmeceutical products. ProPhase Labs Inc (NASDAQ:PRPH) stock opened the session at $1.94, and closed the session at $1.91. The 52 week range of the stock remained $1.41 – $2.98 and the day range was $1.88 – $1.94.
Leave a Reply